The National Agency for Food and Drugs Administration and Control (NAFDAC) has warned against the use of four substandard cough syrups in the country.

NAFDAC said the warning became necessary following the death of 66 children in Gambia after the use of the four cough syrups.

The agency, in a statement made available to The Star on Sunday, listed the four syrups to include Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.

NAFDAC stated that laboratory analysis of samples of the four products revealed that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.

“Diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal. Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.

READ ALSO: NAFDAC to Nigerians: Bleaching products cause cancer, damage kidney

“The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the agency added.

It noted that the products are unsafe, saying their use, especially in children, may result in serious injury or death.

”The products are not registered by NAFDAC, therefore should not be in circulation.

To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions.

“NAFDAC implores importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the substandard cough syrups. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.

“Members of the public in possession of the above-listed products are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.

“If you have these substandard products, please do not use them. If you, or someone you know, have used these products or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional,” NAFDAC stated.

The Star